In July 2017, a patient presented colonization with a multidrugresistant, carbapenemase (KPC-3)-producing Klebsiella pneumoniae isolate. A custom-made, lytic bacteriophage preparation was administered to the patient in December 2017, with subsequent eradication of the microorganism and without adverse effects.
Eradication of a multidrug-resistant, carbapenemase-producing klebsiella pneumoniae isolate following oral and intra-rectal therapy with a custom made, lytic bacteriophage preparation / M. Corbellino, N. Kieffer, M. Kutateladze, N. Balarjishvili, L. Leshkasheli, L. Askilashvili, G. Tsertsvadze, S.G. Rimoldi, D. Nizharadze, N. Hoyle, L. Nadareishvili, S. Antinori, C. Pagani, D.G. Scorza, A.L.L. Romano, S. Ardizzone, P. Danelli, M.R. Gismondo, M. Galli, P. Nordmann, L. Poire. - In: CLINICAL INFECTIOUS DISEASES. - ISSN 1058-4838. - 70:9(2020), pp. 1998-2001. [10.1093/cid/ciz782]
Eradication of a multidrug-resistant, carbapenemase-producing klebsiella pneumoniae isolate following oral and intra-rectal therapy with a custom made, lytic bacteriophage preparation
S. Antinori;A.L.L. Romano;S. Ardizzone;P. Danelli;M.R. Gismondo;M. Galli;
2020
Abstract
In July 2017, a patient presented colonization with a multidrugresistant, carbapenemase (KPC-3)-producing Klebsiella pneumoniae isolate. A custom-made, lytic bacteriophage preparation was administered to the patient in December 2017, with subsequent eradication of the microorganism and without adverse effects.File | Dimensione | Formato | |
---|---|---|---|
ciz782.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
160.9 kB
Formato
Adobe PDF
|
160.9 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.